Direct deep UV lithography to micropattern PMMA for stem cell culture.

Deep UV lithography Microfluidics Microstructures Poly(methyl methacrylate) (PMMA) Stem cell patterning

Journal

Materials today. Bio
ISSN: 2590-0064
Titre abrégé: Mater Today Bio
Pays: England
ID NLM: 101757228

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 17 03 2023
revised: 22 06 2023
accepted: 25 08 2023
medline: 13 9 2023
pubmed: 13 9 2023
entrez: 13 9 2023
Statut: epublish

Résumé

Microengineering is increasingly being used for controlling the microenvironment of stem cells. Here, a novel method for fabricating structures with subcellular dimensions in commonly available thermoplastic poly(methyl methacrylate) (PMMA) is shown. Microstructures are produced in PMMA substrates using Deep Ultraviolet lithography, and the effect of different developers is described. Microgrooves fabricated in PMMA are used for the neuronal differentiation of mouse embryonic stem cells (mESCs) directly on the polymer. The fabrication of 3D, curvilinear patterned surfaces is also highlighted. A 3D multilayered microfluidic chip is fabricated using this method, which includes a porous polycarbonate (PC) membrane as cell culture substrate. Besides directly manufacturing PMMA-based microfluidic devices, an application of the novel approach is shown where a reusable PMMA master is created for replicating microstructures with polydimethylsiloxane (PDMS). As an application example, microchannels fabricated in PDMS are used to selectively expose mESCs to soluble factors in a localized manner. The described microfabrication process offers a remarkably simple method to fabricate for example multifunctional topographical or microfluidic culture substrates outside cleanrooms, thereby using inexpensive and widely accessible equipment. The versatility of the underlying process could find various applications also in optical systems and surface modification of biomedical implants.

Identifiants

pubmed: 37701129
doi: 10.1016/j.mtbio.2023.100779
pii: S2590-0064(23)00239-9
pmc: PMC10494264
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100779

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Stefan Giselbrecht reports a relationship with 300 MICRONS GmbH that includes: board membership and equity or stocks. Roman Truckenmüller and Stefan Giselbrecht are founders and shareholders of 300MICRONS GmbH.

Références

Elife. 2018 Feb 07;7:
pubmed: 29412136
Integr Biol (Camb). 2010 Nov;2(11-12):584-603
pubmed: 20957276
Dev Biol. 1987 May;121(1):1-9
pubmed: 3569655
Biomater Sci. 2021 Nov 23;9(23):7838-7850
pubmed: 34671787
PLoS One. 2013;8(3):e59022
pubmed: 23527077
ACS Appl Mater Interfaces. 2022 Jul 13;:
pubmed: 35830496
Anal Chem. 2007 May 1;79(9):3504-8
pubmed: 17388566
Adv Mater. 2020 Jun;32(24):e1907966
pubmed: 32346909
Lab Chip. 2012 Nov 7;12(21):4508-15
pubmed: 22968416
Curr Protoc Cell Biol. 2001 May;Appendix 3:Appendix 3E
pubmed: 18228287
BMC Dev Biol. 2010 Dec 21;10:121
pubmed: 21176145
Stem Cell Reports. 2017 Aug 8;9(2):654-666
pubmed: 28757164
Lab Chip. 2011 Apr 7;11(7):1368-71
pubmed: 21327278
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2480-7
pubmed: 16477028
Science. 2015 May 15;348(6236):1245075
pubmed: 25977557
Lab Chip. 2005 Dec;5(12):1348-54
pubmed: 16286964
Biomed Microdevices. 2006 Sep;8(3):191-9
pubmed: 16718404
Biomaterials. 2015 Aug;61:316-26
pubmed: 26026844
Adv Mater. 2019 Apr;31(17):e1805764
pubmed: 30767289
Adv Mater. 2011 Nov 9;23(42):4873-9
pubmed: 21935996
Cytometry A. 2004 Apr;58(2):167-76
pubmed: 15057970
Biomaterials. 2012 Jan;33(2):504-14
pubmed: 22014459
Nature. 2006 Jul 27;442(7101):368-73
pubmed: 16871203
Wiley Interdiscip Rev Syst Biol Med. 2018 Sep;10(5):e1422
pubmed: 29600540
Small. 2020 Mar;16(10):e1905422
pubmed: 32064782
World Neurosurg. 2019 Jan;121:222-226
pubmed: 30292660
Methods Mol Biol. 2016;1307:281-7
pubmed: 24859927
MethodsX. 2020 Sep 22;7:101073
pubmed: 33083240
Lab Chip. 2008 Sep;8(9):1570-9
pubmed: 18818815
Small. 2016 Oct;12(39):5407-5413
pubmed: 27555582
Development. 2013 Mar;140(6):1171-83
pubmed: 23444350
Adv Mater. 2022 Jul;34(27):e2200687
pubmed: 35358334

Auteurs

Pinak Samal (P)

MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Universiteitssingel 40, 6229 ER, Maastricht, the Netherlands.

Jay Rabindra Kumar Samal (JR)

MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Universiteitssingel 40, 6229 ER, Maastricht, the Netherlands.

Hoon Suk Rho (HS)

MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Universiteitssingel 40, 6229 ER, Maastricht, the Netherlands.
Mepsgen Co., Ltd., 7F, Hanyang Tower, 12, Beobwon-ro-11-gil, Songpa-gu, Seoul, Republic of Korea.

Denis van Beurden (D)

MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Universiteitssingel 40, 6229 ER, Maastricht, the Netherlands.

Clemens van Blitterswijk (C)

MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Universiteitssingel 40, 6229 ER, Maastricht, the Netherlands.

Roman Truckenmüller (R)

MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Universiteitssingel 40, 6229 ER, Maastricht, the Netherlands.

Stefan Giselbrecht (S)

MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Universiteitssingel 40, 6229 ER, Maastricht, the Netherlands.

Classifications MeSH